University of Cambridge
Case Studies

STORM Therapeutics: Paving the way for new treatments by modifying RNA

19 November 2024
News

Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion

30 June 2020
News

Storm Therapeutics announces appointment of CEO and Chairman

24 February 2017
News

Dr Richard Butt appointed CEO of Apollo Therapeutics

14 April 2016
News

Discovery Fund makes latest investment in Sphere Fluidics

21 May 2010